RenovaCare

RenovaCare, Inc. is a biotechnology company dedicated to developing the first autologous (self-donated) stem cell therapy for human organ regeneration. Our initial product under development targets the largest human organ – the skin. Our flagship technology, the CellMist™ System, utilizes our patented SkinGun™ to spray a liquid suspension of the patient’s stem cells – the CellMist™ Solution – onto wounds. In U.S. clinical investigative studies, the SkinGun™ treatment has demonstrated the potential to naturally and rapidly heal burns and other severe wounds. The CellMist™ System is being developed as a promising new option for burn victims, as well as patients with chronic and acute wounds and scars.